Impact of pharmaceutical care on the health outcomes in patients with systemic arterial hypertension and different care needs: a randomized controlled trial

Not Applicable

• Conditions: Essential (primary) hypertension; Hypertension; I10-I15

• Registration Number: RBR-10j7gj5w
• Lead Sponsor: Faculdade de Ciências Farmacêuticas de Ribeirão Preto

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2013-08-30
• Study Start: 2021-03-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Individuals attended by the Basic Health Unit pharmacy; age 18 years or older; diagnosis of Systemic Arterial Hypertension; use of at least one antihypertensive medication

Exclusion Criteria

Individuals who did not attend the first consultation; individuals who did not attend the monthly meetings for more than four consecutive months

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome: blood pressure parameter (mmHg). Considering the alfa value equal to 5 %, the Z value equal to 1.960 is obtained. From data in the literature, the sum of the initial and final standard deviations was considered equal to 30 mmHg, and a pressure reduction between 5-10 mmHg was considered to be clinically significant. <br><br>;Quality of life evaluation: Conducted through the application of the Mini-Questionnaire on Quality of Life in Hypertension. The questionnaire contains 17 questions, divided into two domains: Mental Status and Somatic Manifestations, and another question which is not included in either of the two domains, relating to general health perception. The patients answered the questions referring to the previous seven days. The higher the score obtained, the lower the patient's perception of quality of life.